Strategies for Delivery of siRNAs to Ovarian Cancer Cells

The unmet need for novel therapeutic options for ovarian cancer (OC) deserves further investigation. Among the different novel drugs, small interfering RNAs (siRNAs) are particularly attractive because of their specificity of action and efficacy, as documented in many experimental setups. However, t...

Descripción completa

Detalles Bibliográficos
Autores principales: Farra, Rossella, Maruna, Matea, Perrone, Francesca, Grassi, Mario, Benedetti, Fabio, Maddaloni, Marianna, El Boustani, Maguie, Parisi, Salvo, Rizzolio, Flavio, Forte, Giancarlo, Zanconati, Fabrizio, Cemazar, Maja, Kamensek, Urska, Dapas, Barbara, Grassi, Gabriele
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6835428/
https://www.ncbi.nlm.nih.gov/pubmed/31652539
http://dx.doi.org/10.3390/pharmaceutics11100547

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6835428/
https://www.ncbi.nlm.nih.gov/pubmed/31652539
http://dx.doi.org/10.3390/pharmaceutics11100547

Ejemplares similares